MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Regulatory/Compliance / Food & Drug Administration (FDA) / UPDATE: FDA warns CareFusion over modified devices, quality control

UPDATE: FDA warns CareFusion over modified devices, quality control

July 24, 2014 By Brad Perriello Leave a Comment

FDA warns CareFusion over modified devices, quality control

UPDATED July 24, 2014, with comment from CareFusion.

CareFusion (NYSE:CFN) drew another warning letter from the FDA last month after an inspection last year revealed unapproved device changes and quality control process problems at a plant in Vernon Hills, Ill.

The June 6 letter asks CareFusion to "immediately cease activities that result in the misbranding or adulteration" of its anesthesia breathing circuit, the Denver ascites shunt and the Denver percutaneous access kit with ascites (peritoneovenous) shunt, including "the commercial distribution of these devices."

Inspections in September and November of last year found that CareFusion made changes to the heated ventilator & anesthesia breathing circuit without letting the FDA know, according to the letter. The San Diego-based company changed materials on the Y-connector used in the device "without studies for leachables and extractables or biological effect," the FDA said.

"The changes to the gas pathway material can impact the safety of the device and quality of the gas condensates for the patient. Therefore, a new 510(k) is required," according to the letter.

Similarly, materials and manufacturing process changes for the Denver ascites shunt and Denver PAK with ascites (peritoneovenous) shunt were not cleared through the watchdog agency, the FDA said.

"These changes can impact the safety and effectiveness of the device; therefore a new 510(k) is required," according to the letter.

CareFusion also "failed to adequately establish procedures for corrective and preventive action" for the Denver devices" and "failed to investigate, where necessary, complaints involving the possible failure of a device to meet any of its specifications," the agency said.

"Specifically, your firm has been aware since August 2011 of complaints of debris/particulate matter with the Denver Ascites Shunt and Percutaneous Access Kit with Ascites Shunt," according to the letter. [Y]our firm has received thirty-two (32) complaints for particulate matter/debris issues associated with the Denver Ascites Shunt and Percutaneous Access Kit with Ascites Shunt since August 2011. Review of ten of the thirty-two complaint investigations revealed that all of the complaints contained the same language, ‘A review of complaint data identified a previous complaint with a similar failure mode. Review of the previous complaint investigation noted corrective actions including remedial training and improved CME (controlled manufacturing environment) requirements were implemented for the previous complaint.’ Your firm could not locate the ‘previous complaint’ or associated complaint investigation and corrective actions referenced in the ten reviewed complaint investigations."

The company also "failed to evaluate and select potential suppliers based on their ability to meet specified requirements" and "failed to adequately establish requirements that must be met by suppliers," the agency said.

"A re-inspection by FDA will be conducted to verify the adequacy and effective implementation of the corrective actions," according to the letter.

CareFusion director of public relations Troy Kirkpatrick told MassDevice.com via email that the company immediately put a hold on shipments of both products after receiving the June 6 FDA warning.

"However, since then we have also met with the FDA and they have approved a plan for the immediate re-commercialization of our Denver shunts product, as well as our plans to transition customers from our heated breathing circuits to Fisher & Paykel heated breathing circuits. We are the exclusive U.S. distributor for Fisher & Paykel respiratory products and sell them as part of our product portfolio," Kirkpatrick wrote. "We take these matters very seriously and have invested significantly to strengthen our quality system and regulatory compliance and controls. We are cooperating fully with FDA to resolve these matters as quickly as possible."

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: CareFusion Corp., Warning Letter

In case you missed it

  • Medtronic faces patent lawsuit over CoreValve tech
  • Orpyx launches sensory insoles with patient monitoring
  • Ortho devicemakers Hensler and Tobra face off in patent lawsuit
  • House bill asks CMS to cover breakthrough devices for Medicare patients
  • Empirical Spine completes enrollment in LimiFlex pivotal trial
  • MolecuLight wins FDA clearance for handheld imaging device
  • Medical device tax will cost 20,000 jobs, report says
  • W.L. Gore officials think they can spur insulin delivery system innovation
  • EPA moves closer to stricter regulations on medtech ethylene oxide sterilization
  • 3DBio Therapeutics wins FDA rare pediatric disease designation for outer ear reconstruction
  • CryoLife wins CE Mark for E-nya thoracic stent graft
  • Edwards projects $5 billion in sales for 2020
  • SPR Therapeutics announces 1000th placement of nerve stimulation device
  • The best places to work for medtech sales reps
  • DePuy Synthes issues urgent field safety notice for USS II Polyaxial 3D heads
  • Haemonetics (HAE) launches SafeTrace Tx in North America
  • Vicarious Surgical wins FDA breakthrough designation for surgical robot

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS